Insider Stock Trading History of Kroll Mark W


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kroll Mark W since year 2005. The trader's CIK number is 1259254. At the time of this reporting, Kroll Mark W is the Director of Haemonetics Corp . (stock ticker symbol HAE). See this page for all insider trading activities at Haemonetics Corp .

Note that in the past KROLL MARK W also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Kroll Mark W since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-05-15 HAE Haemonetics Corp Option Ex 8,580 27.24 233,719
2017-05-15 HAE Haemonetics Corp Sale 8,580 41.49 355,992
2015-05-08 TASR Taser International Inc Option Ex 90,134 13.42 1,209,868
2015-02-27 HAE Haemonetics Corp Sale 11,328 44.80 507,483
2015-02-27 HAE Haemonetics Corp Option Ex 11,328 29.23 331,117
2014-11-03 TASR Taser International Inc Option Ex 44,034 11.37 500,666
2014-02-28 TASR Taser International Inc Option Ex 24,000 14.40 345,720
2013-12-16 TASR Taser International Inc Option Ex 24,000 12.96 310,920
2013-09-05 TASR Taser International Inc Option Ex 47,620 8.26 393,341
2012-11-19 HAE Haemonetics Corp Option Ex 4,592 49.92 229,232
2012-11-19 HAE Haemonetics Corp Sale 4,592 80.13 367,956
2012-11-16 HAE Haemonetics Corp Sale 6,000 79.67 478,032
2012-11-16 HAE Haemonetics Corp Option Ex 6,000 52.76 316,560
2012-08-17 TASR Taser International Inc Option Ex 90,074 2.92 263,196
2012-08-20 TASR Taser International Inc Option Ex 83,258 2.88 239,366
2012-05-04 HAE Haemonetics Corp Option Ex 20,000 48.77 975,300
2012-05-04 HAE Haemonetics Corp Sale 20,000 71.09 1,421,759
2010-03-17 TASR Taser International Inc Option Ex 30,000 3.58 107,550
2007-10-26 TASR Taser International Inc Option Ex 50,000 8.46 422,750

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kroll Mark W (Director of Haemonetics Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.